161 related articles for article (PubMed ID: 38248871)
1. Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression.
Yang Z; Hou Y; Li J; Xu D; Yang Z; Wang X
Int J Immunopathol Pharmacol; 2024; 38():3946320241227320. PubMed ID: 38248871
[No Abstract] [Full Text] [Related]
2. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma.
Gong M; Feng S; Zhou D; Luo J; Lin T; Qiu S; Yuan R; Dong W
Eur J Med Res; 2023 Oct; 28(1):440. PubMed ID: 37848987
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ITGB2-AS1 promotes the progression of clear cell renal cell carcinoma by modulating miR-328-5p/HMGA1 axis.
Zhang W; Lu Y; Shi H; Li X; Zhang Z; Deng X; Yang Y; Wan B
Hum Cell; 2021 Sep; 34(5):1545-1557. PubMed ID: 34170494
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
Zhong L; Zhong X
Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
Wang LN; Zhu XQ; Song XS; Xu Y
J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
[TBL] [Abstract][Full Text] [Related]
7. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000-
Nianyong Y; Li G
Aging (Albany NY); 2023 Jun; 15(12):5399-5411. PubMed ID: 37379126
[TBL] [Abstract][Full Text] [Related]
9. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
Zhou Y; Zhang Z; Wo M; Xu W
Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
[TBL] [Abstract][Full Text] [Related]
10.
Liu Q; Lei C
Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
[TBL] [Abstract][Full Text] [Related]
11. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
[TBL] [Abstract][Full Text] [Related]
12. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS.
Jiao M; Guo H; Chen Y; Li L; Zhang L
Biomed Pharmacother; 2020 Aug; 128():110323. PubMed ID: 32526457
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00565 regulates
Meng B; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Yan C
Chin J Physiol; 2023; 66(6):474-484. PubMed ID: 38149560
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
[TBL] [Abstract][Full Text] [Related]
16. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of lncRNA ZNF582-AS1 due to DNA hypermethylation promotes clear cell renal cell carcinoma growth and metastasis by regulating the N(6)-methyladenosine modification of MT-RNR1.
Yang W; Zhang K; Li L; Xu Y; Ma K; Xie H; Zhou J; Cai L; Gong Y; Gong K
J Exp Clin Cancer Res; 2021 Mar; 40(1):92. PubMed ID: 33691743
[TBL] [Abstract][Full Text] [Related]
19. Determination of the key ccRCC-related molecules from monolayer network to three-layer network.
Wu Y; Ding Y; Wang J; Wang X
Cancer Genet; 2021 Aug; 256-257():40-47. PubMed ID: 33887693
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous miRNA-mRNA Regulatory Networks of Visceral and Subcutaneous Adipose Tissue in the Relationship Between Obesity and Renal Clear Cell Carcinoma.
Liu Y; Liu Y; Hu J; He Z; Liu L; Ma Y; Wen D
Front Endocrinol (Lausanne); 2021; 12():713357. PubMed ID: 34621242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]